An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans

Area of Science:

• Genetics
• Metabolic Diseases
• Human Genomics

Background:

• Type 2 Diabetes (T2D) is a complex metabolic disorder with a significant genetic component.
• Understanding the genetic architecture of T2D across the allele frequency spectrum is crucial for elucidating disease mechanisms.

Purpose of the Study:

• To perform a comprehensive meta-analysis of genome-wide association studies (GWAS) to identify novel T2D-associated genetic variants.
• To characterize the contribution of common and low-frequency variants to T2D susceptibility.
• To explore the biological underpinnings of identified T2D loci through functional annotations.

Main Methods:

• Meta-analysis of GWAS data from over 26,000 T2D cases and 130,000 controls of European ancestry.
• Imputation using the 1000 Genomes reference panel.
• Replication of promising signals in independent cohorts.
• Fine-mapping and stratification of loci based on T2D-related quantitative traits.

Main Results:

• Identification of 13 novel T2D-associated loci, bringing the total to 128 independent signals at 113 loci.
• All novel associations were attributed to common single nucleotide variants.
• Credible sets for causal variants were refined, indicating resolution to common risk haplotypes.
• Tissue-specific enrichment of regulatory annotations was observed, implicating pancreatic islets for insulin secretion and adipocytes/monocytes/hepatocytes for insulin action.

Conclusions:

• Common variants of modest effect play a predominant role in T2D pathogenesis.
• The study expands the landscape of T2D genetic associations and highlights the diversity of biological mechanisms involved.
• Findings provide insights into tissue-specific regulatory functions influencing T2D risk.